title: [Botulinum toxin A intradetrusor injections in consultation: single center experience during 2 years].
abstract: OBJECTIVE
  In departments of urology, intradetrusor botulinum toxin injections are routinely performed in ambulatory outpatient clinic. The aim of the study was to assess the satisfaction level of patients treated with this technique.
  
  
  METHODS
  A satisfaction questionnaire was carried out by telephone for all patients treated in ambulatory outpatient clinic from 2009 to 2010.
  
  
  RESULTS
  Twenty-six patients were treated in consultation during the studied period for a total of 46 sessions of injections. The average age was 48.81 (±16.78) years. An injection programme containing 20 or 30 points was performed after a local anesthetic. Twenty patients answered the questionnaire. As regards the organization of the injections, 12 patients (60%) declared to have been satisfied and seven very satisfied (35%). Eight patients (40%) were very satisfied with the management of the pain and six (30%) satisfied versus only one (5%) not satisfied at all. For the time spent in the hospital during the injections, 10 (50%) were satisfied and seven (35%) very satisfied. Only 4 patients (20%) would have preferred to be hospitalized in an outpatient facility. In cases of new injections, 18 (90%) patients would have preferred an identical coverage. Finally, 17 (85%) would recommend this procedure to one of their close relations.
  
  
  CONCLUSIONS
  Our results showed that the majority of patients were completely satisfied with the injection programme. However, as patients are not currently covered by the national health system for these injections, this might hinder the development of this procedure.
authors.affiliation: Service d'urologie, CHU de Caen, avenue de la Côte-de-nacre, 14000 Caen, France. fx nouhaud@hotmail.fr
authors.forename: F-X
authors.initials: FX
authors.lastname: Nouhaud
authors.forename: S
authors.initials: S
authors.lastname: Le Gal
authors.forename: C
authors.initials: C
authors.lastname: Chahwan
authors.forename: A
authors.initials: A
authors.lastname: Doerfler
authors.forename: H
authors.initials: H
authors.lastname: Bensadoun
authors.forename: S
authors.initials: S
authors.lastname: Le Toquin
mesh_terms: D000283:Administration, Intravesical; D000553:Ambulatory Care; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009465:Neuromuscular Agents / Q000008:administration & dosage*; D017060:Patient Satisfaction; D012189:Retrospective Studies; D013997:Time Factors; D053201:Urinary Bladder, Overactive / Q000209:etiology*
chemical_list: D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A